{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:41:03Z","timestamp":1783539663530,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010780","name":"Celltrion Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010780","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Arenapharm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10620-021-07104-0","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T15:03:05Z","timestamp":1624892585000},"page":"1271-1277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6955-1447","authenticated-orcid":false,"given":"Rajen","family":"Parekh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan C.","family":"Ungaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica J.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasi","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Frederic","family":"Colombel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Kappelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"key":"7104_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/tmi.13383","volume":"25","author":"TP Velavan","year":"2020","unstructured":"Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health 2020;25:278\u2013280. https:\/\/doi.org\/10.1111\/tmi.13383.","journal-title":"Trop Med Int Health"},{"key":"7104_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","volume":"20","author":"X Cao","year":"2020","unstructured":"Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol 2020;20:269\u2013270. https:\/\/doi.org\/10.1038\/s41577-020-0308-3.","journal-title":"Nat Rev Immunol"},{"key":"7104_CR3","unstructured":"Allen J, Almukhtar S, Aufrichtig A, Barnard A, Bloch M, Cahalan S, Cai W, Calderone J, Collins K, Conlen M, Cook L, Gianordoli G, Harmon A, Harris R, Hassan A, Huang J, Issawi D, Ivory D, Lai K, Lemonides A, Lutz E, McCann A, Oppel R, Patel J, Saldanha A, Semple K, Seroussi A, Shaver J, Singhvi A, Smart C, Smith M, Sun A, Taylor R, Watkins D, Williams T, Wu J, Yourishl K. Coronavirus World Map: Tracking the Global Outbreak. The New York Times, 22 Mar. 2021. www.nytimes.com\/interactive\/2020\/world\/coronavirus-maps.html."},{"key":"7104_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00190","author":"H Li","year":"2020","unstructured":"Li H, Wang S, Zhong F, Bao W, Li Y, Liu L, Wang H, He Y. Age-dependent risks of incidence and mortality of COVID-19 in Hubei Province and other parts of China. Front Med. 2020. https:\/\/doi.org\/10.3389\/fmed.2020.00190.","journal-title":"Front Med"},{"key":"7104_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/s1473-3099(20)30195-x","volume":"20","author":"D Baud","year":"2020","unstructured":"Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis 2020;20:773. https:\/\/doi.org\/10.1016\/s1473-3099(20)30195-x.","journal-title":"Lancet Infect Dis"},{"key":"7104_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s40615-020-00934-0","author":"Z Wiley","year":"2021","unstructured":"Wiley Z, Kubes J, Cobb J, Jacob J, Franks N, Plantinga L, Lea J. Age, comorbid conditions, and racial disparities in COVID-19 outcomes. J Racial Ethn Health Disparities. 2021. https:\/\/doi.org\/10.1007\/s40615-020-00934-0.","journal-title":"J Racial Ethn Health Disparities"},{"key":"7104_CR7","doi-asserted-by":"crossref","unstructured":"Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y, Liu X, Chen R, Tang C, Wang T, Ou C, Li L, Chen P, Sang L, Wang W, Li J, Li C, Ou L, Cheng B, Xiong S, Ni Z, Xiang J, Hu Y, Liu L, Shan H, Lei C, Peng Y, Wei L, Liu Y,Hu Y, Peng P, Wang J, Liu J, Chen Z, Li G, Zheng Z, Qiu S, Luo J, Ye C, Zhu S, Cheng L, Ye F, Li S, Zheng J, Zhang N, Zhong N, He J. Comorbidity and Its Impact on 1590 Patients with COVID-19 in China: A Nationwide Analysis. European Respiratory Society, 1 May 2020. https:\/\/erj.ersjournals.com\/content\/55\/5\/2000547.short.","DOI":"10.1101\/2020.02.25.20027664"},{"key":"7104_CR8","doi-asserted-by":"publisher","unstructured":"Bezzio C, Saibeni S, Variola A, Allocca M, Massari A, Garardi V, Casini V, Ricci C, Zingone F, Amato A, Caprioli F, Lenti M, Vigan\u00f2 C, Ascolani M, Bossa F, Castiglione F, Cortelezzi C, Grossi L, Milla M, Morganti D, Pastorelli L, Ribaldone D, Sartini A, Soriano A, Manes G, Danese S, Fantini M, Armuzzi A, Daperno M, Fiorino G. Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut 2020;69:1213\u20131217. https:\/\/doi.org\/10.1136\/gutjnl-2020-321411.","DOI":"10.1136\/gutjnl-2020-321411"},{"key":"7104_CR9","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1016\/j.cgh.2020.08.003","volume":"18","author":"F D\u2019Amico","year":"2020","unstructured":"D\u2019Amico F, Danese S, Peyrin-Biroulet L. Systematic review on inflammatory bowel disease patients with coronavirus disease 2019: it is time to take stock. Clin Gastroenterol Hepatol 2020;18:2689\u20132700. https:\/\/doi.org\/10.1016\/j.cgh.2020.08.003.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7104_CR10","doi-asserted-by":"publisher","unstructured":"Pepys M, Druguet M, Klass H, Dash A, Mirjah D, Petrie A. Immunological studies in inflammatory bowel disease. In Ciba Foundation Symposium 46\u2014Immunology of the Gut Novartis Foundation Symposia, 2008, pp. 283\u2013304. https:\/\/doi.org\/10.1002\/9780470720288.ch14.","DOI":"10.1002\/9780470720288.ch14"},{"key":"7104_CR11","first-page":"116","volume":"26","author":"L Biancone","year":"1994","unstructured":"Biancone L, Scopinaro F, Maletta M et al. Circulating D dimer in inflammatory bowel disease. Ital J Gastroenterol 1994;26:116\u2013120.","journal-title":"Ital J Gastroenterol"},{"key":"7104_CR12","unstructured":"Gupta S. Elevated Level of C Reactive Protein May Predict Risk for Worsening COVID-19. Infectious Disease Advisor, 14 May 2020. www.infectiousdiseaseadvisor.com\/home\/topics\/covid19\/high-crp-associated-with-increased-likelihood-of-progression-to-severe-covid-19\/."},{"key":"7104_CR13","unstructured":"Farkas J. PulmCrit Wee: D-Dimer Cutoffs to Predict Thrombosis in COVID-19. EMCrit Project, 10 April 2020. http:\/\/emcrit.org\/pulmcrit\/dimer-cutoff-covid\/."},{"key":"7104_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.crohns.2012.02.015","volume":"7","author":"AN Ananthakrishnan","year":"2013","unstructured":"Ananthakrishnan AN, Mcginley EL. Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. J Crohn\u2019s Colitis 2013;7:107\u2013112. https:\/\/doi.org\/10.1016\/j.crohns.2012.02.015.","journal-title":"J Crohn's Colitis"},{"key":"7104_CR15","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/s0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley D, Brown M, Sanchez E, Tattersall R, Manson J. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033\u20131034. https:\/\/doi.org\/10.1016\/s0140-6736(20)30628-0.","journal-title":"Lancet"},{"key":"7104_CR16","doi-asserted-by":"publisher","unstructured":"Horby P, Lim W, Emberson J, Haynes R, Landray M. Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report. MedRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.06.22.20137273.","DOI":"10.1101\/2020.06.22.20137273"},{"key":"7104_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.crohns.2010.09.008","volume":"5","author":"J Haapam\u00e4ki","year":"2011","unstructured":"Haapam\u00e4ki J, Roine R, Turunen U, F\u00e4rkkil\u00e4 M, Arkkilla P. Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease. J Crohn\u2019s Colitis 2011;5:41\u201347. https:\/\/doi.org\/10.1016\/j.crohns.2010.09.008.","journal-title":"J Crohn's Colitis"},{"key":"7104_CR18","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.07.020","author":"EJ Brenner","year":"2020","unstructured":"Brenner E, Ungaro R, Gearry R, Kaplan G, Kissous-Hunt M, Lewis J, Ng S, Rahier J, Reinisch W, Ruemmele F, Steinwurz F, Underwood F, Zhang X, Colombel J, Kappelman M. CME exam 1: corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology. 2020. https:\/\/doi.org\/10.1053\/j.gastro.2020.07.020.","journal-title":"Gastroenterology"},{"key":"7104_CR19","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2019. https:\/\/www.R-project.org\/."},{"key":"7104_CR20","doi-asserted-by":"publisher","unstructured":"Wickham H, Averick M, Bryan J, Chang W, McGowan L, Fran\u00e7ois R, Grolemund G, Hayes A, Henry L, Hester J, Kuhn M, Pedersen T, Miller E, Bache S, M\u00fcller K, Ooms J, Robinson D, Seidel D, Spinu V, Takahashi K, Vaughan D, Wilke C, Woo K, Yutani H. Welcome to the tidyverse. J Open Source Softw 2019;4:1686. https:\/\/doi.org\/10.21105\/joss.01686.","DOI":"10.21105\/joss.01686"},{"key":"7104_CR21","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.06.003","author":"S Singh","year":"2020","unstructured":"Singh S, Khan A, Chowdhry M, Bilal M, Kochhar G, Clarke K. Risk of severe coronavirus disease 2019 in patients with inflammatory bowel disease in the United States: a multicenter research network study. Gastroenterology. 2020. https:\/\/doi.org\/10.1053\/j.gastro.2020.06.003.","journal-title":"Gastroenterology"},{"key":"7104_CR22","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s11255-020-02451-9","volume":"52","author":"BM Henry","year":"2020","unstructured":"Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol 2020;52:1193\u20131194. https:\/\/doi.org\/10.1007\/s11255-020-02451-9.","journal-title":"Int Urol Nephrol"},{"key":"7104_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25889","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Lian N, Deng Y, Lin S. The impact of COPD and smoking history on the severity of COVID-19: a systemic review and meta-analysis. J Med Virol. 2020. https:\/\/doi.org\/10.1002\/jmv.25889.","journal-title":"J Med Virol"},{"key":"7104_CR24","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1161\/strokeaha.120.030365","volume":"51","author":"C Qin","year":"2020","unstructured":"Qin C, Zhou L, Hu Z, Yang S, Zhang S, Chen M, Yu H, Tian D, Wang W. Clinical characteristics and outcomes of COVID-19 patients with a history of stroke in Wuhan, China. Stroke 2020;51:2219\u20132223. https:\/\/doi.org\/10.1161\/strokeaha.120.030365.","journal-title":"Stroke"},{"key":"7104_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-020-01328-8","author":"J Rico-Mesa","year":"2020","unstructured":"Rico-Mesa J, Rosas D, Ahmadian-Tehrani A, White A, Anderson A, Chilton R. The role of anticoagulation in COVID-19-induced hypercoagulability. Curr Cardiol Rep. 2020. https:\/\/doi.org\/10.1007\/s11886-020-01328-8.","journal-title":"Curr Cardiol Rep"},{"key":"7104_CR26","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.2337\/dc20-0576","volume":"43","author":"Q Cai","year":"2020","unstructured":"Cai Q, Chen F, Wang T, Luo F, Liu X, Wu Q, He Q, Wang Z, Liu Y, Liu L, Chen J, Xu L. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care 2020;43:1392\u20131398. https:\/\/doi.org\/10.2337\/dc20-0576.","journal-title":"Diabetes Care"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07104-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-07104-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07104-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T16:26:23Z","timestamp":1648916783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-07104-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["7104"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-07104-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,28]]},"assertion":[{"value":"23 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RP reports no conflict of interest. XZ reports no conflict of interest. RCU has served as a consultant and\/or advisory board member for Bristol Myers Squibb, Eli Lilly, Janssen, Pfizer and Takeda. He has received research support from AbbVie, Boehringer Ingelheim and Pfizer. He is supported by a Career Development Award from the National Institutes of Health (K23KD111995\u201001A1). EJB reports no conflict of interest. MA reports no conflict of interest. JFC reports receiving research grants from AbbVie, Janssen Pharmaceuticals and Takeda; receiving payment for lectures from AbbVie, Amgen, Allergan, Inc. Ferring Pharmaceuticals, Shire, and Takeda; receiving consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Genentech, Janssen Pharmaceuticals, Landos, Ipsen, Medimmune, Merck, Novartis, Pfizer, Shire, Takeda, Tigenix, Viela bio; and hold stock options in Intestinal Biotech Development and Genfit. MDK has consulted for Abbvie, Janssen, Pfizer, and Takeda, is a shareholder in Johnson & Johnson, and has received research support from Pfizer, Takeda, Janssen, Abbvie, Lilly, Genentech, Boehringer Ingelheim, Bristol Myers Squibb, Celtrion, and Arenapharm.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Each SECURE-IBD survey item met criteria for de-identified data, in accordance with the HIPAA Safe Harbor De-Identification standards. The UNC-Chapel Hill Office for Human Research Ethics has determined that the storage and analysis of de-identified data for this project does not constitute human subjects research as defined under federal regulations [45 CFR 46.102 and 21 CFR 56.102] and does not require IRB approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}